Novo Nordisk halts phase III FLOW trial of semaglutide early due to strong efficacy 2023-10-13
Leqembi Receives Approval in Japan for the Treatment of Alzheimers Disease: A Milestone in Slowing Cognitive Decline 2023-10-13
Indias Quest for Pharma Self-Sufficiency: Reducing Dependence on China 2023-10-13
ADDRESS THE INDUSTRY’S CONCERN 2023-09-20
Hansoh Pharmas Zolbetuximab Receives BLA Acceptance for Gastric Cancer Treatment in China 2023-09-01
GlaxoSmithKline Pharmaceuticals Reports 11% Rise in Q1 Profit Driven by Strong Demfor Vaccines 2023-08-11
GLP-1 Weight Loss Drugs: A Review of Current Drugs Developments 2023-08-11
Hansoh Pharmas Zolbetuximab Receives BLA Acceptance for Gastric Cancer Treatment in China 2023-08-11
Betta Pharmaceuticals CFT8919 approved for clinical trials in the United States 2023-07-12
Hengrui Pharmaceuticals innovative drug HRS-4357 injection has been approved for clinical use in prostate cancer 2023-07-12
Nine key words & hot events in the pharmaceutical industry in 2023 H1 2023-07-12
Elon Musk takes ketamine for depression parties? The Controversial Use of Ketamine: A Potent Psychedelic Drug 2023-07-03
Pimicotinib was approved by EMA Priority Drug Program 2023-06-14
Zhaoke Ophthalmology joins forces with Eyedetec Medical 2023-06-14
RemeGen ADC drug RC108 combined with PD-1 has been approved for the treatment of solid tumors in phase Ⅰb/Ⅱ clinical trial 2023-06-14
Boanbiodulaglutide injection BA5101 completed phase III clinical trial 2023-06-08
With annual sales of times="32".4 billion, the race is on for the first copy of this innovative drug 2023-06-08
The legendary Bio-Citagiorencel reduces the risk of disease progression or death by 74% 2023-06-08
Antidepressant market usher in new opportunities, see "a brother" status fall to who hand? 2023-05-11
Analysis of 70 macrocyclic drugs approved by the FDA 2023-05-11
$860 million market size, PDC drug development market analysis 2023-05-11
Only 3 drugs have been approved! Frozen life, times="32".16 million worth of drugs 2023-05-11
Enbio: Partnered with BioNTech to advance the development of next-generation antibody conjugated drugs (ADCs) 2023-04-20
Cure diabetes obesity with printed materials? Novo Nordisk Introduces Cell Therapy for
.6 billion 2023-04-20
Multiple product indications withdrawn, FDA accelerated Approval How to reform? 2023-04-20
Maxpro: Completed merger with SPAC Maxpro listed on Nasdaq 2023-03-31
Meinol completed the B round financing of over 100 million yuan, continued to accelerate the overall layout of CXO industry 2023-03-31
Received orphan drug recognition! Shanghai Pharmaceutical SPH4336 breakthrough liposarcoma 2023-03-31
Yi Neng Pharmaceutical, A leading TCM CXO enterprise, has completed a series of financing of over 100 million yuan, enabling the modernization innovation research development of TCM 2023-03-31
After 20 years of failure, Is there Hope for targeted Aβ therapy for AD? 2023-03-20
$161 million! China Biopharmaceutical completes acquisition of F-star Therapeutics 2023-03-10
The different paths of Chinese foreign diabetes giants: double males double bears 2023-03-03
共
1513 个 页次:
2 /
48 页
32 个/页
首页 上一页 下一页 尾页
转到：
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
Our Advantages of Reports
①All reports written by ourselves
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
News 
